Immix Biopharma, Inc.IMMXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P40
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2024-40.11%
2023-87.44%
202266.25%
2021-2024.28%
2020-17.99%
20190.00%